IL-19 Protein (AA 25-177) (Fc Tag)
-
- Target Alle IL-19 (IL19) Proteine anzeigen
- IL-19 (IL19) (Interleukin 19 (IL19))
- Protein-Typ
- Recombinant
- Proteineigenschaft
- AA 25-177
-
Spezies
- Human
-
Quelle
- HEK-293 Cells
- Aufreinigungstag / Konjugat
- Dieses IL-19 Protein ist gelabelt mit Fc Tag.
- Verwendungszweck
- Human IL-19 Protein
- Sequenz
- Leu25-Ala177
- Produktmerkmale
- Recombinant Human IL-19 Protein is expressed from HEK293 with hFc tag at the C-Terminus.It contains Leu25-Ala177.
- Reinheit
- > 95 % as determined by Tris-Bis PAGE,> 95 % as determined by HPLC
- Sterilität
- 0.22 μm filtered
- Endotoxin-Niveau
- Less than 1EU per μg by the LAL method.
-
-
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- Supplied as 0.22μm filtered solution in 20 mM Tris, 500 mM NaCl ( pH 8.0).
- Lagerung
- -80 °C
- Informationen zur Lagerung
- Valid for 12 months from date of receipt when stored at -80°C., Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles.
- Haltbarkeit
- 12 months
-
- Target
- IL-19 (IL19) (Interleukin 19 (IL19))
- Andere Bezeichnung
- IL-19 (IL19 Produkte)
- Synonyme
- IL-10C Protein, MDA1 Protein, NG.1 Protein, ZMDA1 Protein, IL19 Protein, interleukin 19 Protein, IL19 Protein, Il19 Protein
- Hintergrund
- Interleukin-19 (IL-19) has been shown to be involved in coronary artery diseases and atherosclerosis, while its expression in myocardial infarction is poorly understood. In this study, the dynamic increase in circulating IL-19 in acute ST-segment elevation myocardial infarction (STEMI) patients was detected.IL-19 is correlated with the severity of acute myocardial infarction, which may be a new idea for the clinical treatment of myocardial infarction.
- Molekulargewicht
- 44.6 kDa. Due to glycosylation, the protein migrates to 55-60 kDa based on Tris-Bis PAGE result.
-